7EOT image
Deposition Date 2021-04-22
Release Date 2021-06-30
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7EOT
Title:
Structure of the human GluN1/GluN2A NMDA receptor in the CGP-78608/glutamate bound state
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Glutamate receptor ionotropic, NMDA 2A
Gene (Uniprot):GRIN2A
Mutations:L794C
Chain IDs:A, C
Chain Length:853
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Glutamate receptor ionotropic, NMDA 1
Gene (Uniprot):GRIN1
Mutations:E698C
Chain IDs:B, D
Chain Length:847
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
Neuron 109 2443 2456.e5 (2021)
PMID: 34186027 DOI: 10.1016/j.neuron.2021.05.031

Abstact

N-methyl-D-aspartate (NMDA) receptors are glutamate-gated calcium-permeable ion channels that are widely implicated in synaptic transmission and plasticity. Here, we report a gallery of cryo-electron microscopy (cryo-EM) structures of the human GluN1-GluN2A NMDA receptor at an overall resolution of 4 Å in complex with distinct ligands or modulators. In the full-length context of GluN1-GluN2A receptors, we visualize the competitive antagonists bound to the ligand-binding domains (LBDs) of GluN1 and GluN2A subunits, respectively. We reveal that the binding of positive allosteric modulator shortens the distance between LBDs and the transmembrane domain (TMD), which further stretches the opening of the gate. In addition, we unexpectedly visualize the binding cavity of the "foot-in-the-door" blocker 9-aminoacridine within the LBD-TMD linker region, differing from the conventional "trapping" blocker binding site at the vestibule within the TMD. Our study provides molecular insights into the crosstalk between LBDs and TMD during channel activation, inhibition, and allosteric transition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures